Search results
Fact checking claims about vaccines as new COVID-19 variant emerges
Kentucky Lantern via Yahoo News· 4 hours agoIn the last month, new COVID-19 variants — known as FLiRT and part of the omicron family — emerged...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 23 hours agoPreviously, the FDA expected to make it decision by May 12. Moderna emphasized the FDA has not said...
Moderna Stock Seesaws After The FDA Throws It A Curveball
Investor's Business Daily· 5 days agoThe FDA was due to make a decision by May 12. Moderna emphasized the FDA has not said it found any...
What's Going With Moderna Stock On Friday? - Moderna (NASDAQ:MRNA)
Benzinga· 5 days agoThe agency, citing administrative constraints, does not expect to complete its review of the Biologics License Application (BLA) for mRNA-1345, Moderna’s investigational respiratory ...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 23 hours agoThe deal is a negative for Covid vaccine rivals Pfizer and Moderna, Leerink Partners analyst David...
AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation -...
EconoTimes· 6 days agoThe Oxford-AstraZeneca vaccine was a critical part of the COVID-19 pandemic response. This EU...
A 'Decline in Demand' Leads to the End for This COVID Vaccine
newser· 7 days agoMore than 3 billion doses of the vaccine were administered in other countries around the world...
AstraZeneca withdraws Covid-19 vaccine, citing low demand - Boston News, Weather, Sports | WHDH...
7 News Boston· 6 days agoAstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a...
AstraZeneca withdraws COVID-19 vaccine, citing declining demand
Healthcare Dive· 7 days agoAstraZeneca will no longer manufacture or supply its COVID-19 vaccine Vaxzevria, announcing Tuesday it is voluntarily withdrawing the shot due to a “decline in demand,” a ...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 23 hours agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...